IJIE
Vol. 5 No. 6 (2022): IJIE

Pathogenetic Treatment of Gonarthrosis Using Autogenic Growth Factors

Amrilloyevich, Nematov Dilshod (Unknown)



Article Info

Publish Date
11 Jun 2022

Abstract

In 25% of cases, therapy leads to the development of unwanted drug reactions, and in 5% of patients it can be life-threatening. Long-term use of NSAIDs often exacerbates the course. To reduce the dose or completely cancel NSAIDs, chondroprotectors, glucosamine and chondroitin sulfate, are included in the complex therapy of OA. With the ineffectiveness of NSAIDs and local forms of OA, intra-articular injections of hyaluronic acid preparations are justified. They are able to stimulate the production of endogenous HA, have anti-inflammatory, regenerative and chondroprotective effects. Stimulation of the production of endogenous HA can also be achieved by intra-articular administration of the patient's autoplasma enriched with platelets (AutoPRP). Platelet autogenous growth factors, in particular, transforming growth factor beta TGF-β, can achieve suppression of destruction processes in the joint [1.3.5.7.9.11].

Copyrights © 2022






Journal Info

Abbrev

IJIE

Publisher

Subject

Education

Description

International Journal on Integrated Education (IJIE) 2620-3502 is a peer-reviewed, open-access scholarly journal, publishing high-quality manuscripts in multidisciplinary research areas. IJIE accepts papers in the forms of original research articles, review articles, book reviews, case reports, and ...